This topic contains a solution. Click here to go to the answer

Author Question: If a new drug is developed that is a potent CB1 agonist, one would expect this drug to a. produce ... (Read 97 times)

Alygatorr01285

  • Hero Member
  • *****
  • Posts: 564
If a new drug is developed that is a potent CB1 agonist, one would expect this drug to
 
  a. produce a high similar to that of marijuana.
  b. repair memory in elderly dementia patients.
  c. erode the moral values of this country.
  d. suppress D2 receptors.
  e. produce conditioned aversion for the areas in which the drug is experienced.

Question 2

Research suggests that habitual use of cannabis in adolescence is correlated with the development of
 
  a. panic disorder.
  b. depression.
  c. posttraumatic stress disorder.
  d. schizophrenia.
  e. anxiety disorder.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Liamb2179

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

Answer: a. produce a high similar to that of marijuana.

Answer to Question 2

Answer: d. schizophrenia.




Alygatorr01285

  • Member
  • Posts: 564
Reply 2 on: Jun 22, 2018
Excellent


milbourne11

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library